- Home
- PMI vs PRME Comparison
PMI vs PRME Comparison
Compare PMI & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMI
- PRME
- Stock Information
- Founded
- PMI 1981
- PRME 2019
- Country
- PMI United States
- PRME United States
- Employees
- PMI N/A
- PRME N/A
- Industry
- PMI
- PRME Medicinal Chemicals and Botanical Products
- Sector
- PMI
- PRME Health Care
- Exchange
- PMI Nasdaq
- PRME Nasdaq
- Market Cap
- PMI 605.1M
- PRME 693.5M
- IPO Year
- PMI 2025
- PRME 2022
- Fundamental
- Price
- PMI $9.88
- PRME $6.07
- Analyst Decision
- PMI
- PRME Buy
- Analyst Count
- PMI 0
- PRME 6
- Target Price
- PMI N/A
- PRME $8.88
- AVG Volume (30 Days)
- PMI 2.2M
- PRME 3.8M
- Earning Date
- PMI 01-01-0001
- PRME 11-11-2025
- Dividend Yield
- PMI N/A
- PRME N/A
- EPS Growth
- PMI N/A
- PRME N/A
- EPS
- PMI N/A
- PRME N/A
- Revenue
- PMI $4,461,000.00
- PRME $4,961,000.00
- Revenue This Year
- PMI N/A
- PRME $179.58
- Revenue Next Year
- PMI N/A
- PRME N/A
- P/E Ratio
- PMI N/A
- PRME N/A
- Revenue Growth
- PMI 1.36
- PRME 739.42
- 52 Week Low
- PMI $4.19
- PRME $1.11
- 52 Week High
- PMI $10.15
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- PMI N/A
- PRME 66.30
- Support Level
- PMI N/A
- PRME $4.87
- Resistance Level
- PMI N/A
- PRME $5.63
- Average True Range (ATR)
- PMI 0.00
- PRME 0.50
- MACD
- PMI 0.00
- PRME 0.11
- Stochastic Oscillator
- PMI 0.00
- PRME 63.87
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.